U.S. Household Products Stock News

Compugen (CGEN) has just reported its FY 2025 results, with Q3 revenue of US$1.9 million and a basic EPS loss of US$0.07. Trailing twelve month figures show revenue of US$6.9 million and a basic EPS loss of US$0.30. The company has seen quarterly revenue range from US$1.3 million to US$2.3 million in FY 2025 so far, with basic EPS losses between US$0.07 and US$0.08 over the same stretch. This sets up a picture in which top line consistency still sits alongside negative earnings. With revenue...

What Hinge Health’s latest trading move signals for investors Hinge Health (HNGE) has caught investor attention after a recent move in its share price, with the stock closing at US$42.76 as short term returns and fundamentals offer a mixed picture. See our latest analysis for Hinge Health. The recent 7 day share price return of 11.21% and 30 day share price return of 22.52% sit against a weaker 90 day share price return of 8.16% and year to date share price return of 6.15%. This suggests...

In recent days, ZoomInfo Technologies reported that its upmarket customers now account for 74% of its business, Copilot AI has reached 20% of annual contract value, and the company approved an additional US$1.00 billion for share repurchases while providing cautious 2026 revenue guidance. At the same time, supportive comments from Nvidia CEO Jensen Huang about AI complementing enterprise software reframed how investors view ZoomInfo’s AI-focused evolution. We’ll now examine how Nvidia’s...

Option Care Health (OPCH) shares came into focus after the company reported fourth quarter and full year 2025 results, combining higher sales with margin pressure from biosimilar adoption, reaffirmed guidance and a larger share repurchase program. See our latest analysis for Option Care Health. At a share price of US$32.46, Option Care Health has seen pressure recently, with a 7 day share price return of a 10.06% decline and a 1 month share price return of a 4.53% decline. This is in contrast...

ESAB Corporation recently reported fourth-quarter 2025 results showing higher sales but lower earnings year-on-year, while its Board affirmed a quarterly cash dividend of US$0.10 per share payable on April 17, 2026. Alongside this, increased institutional ownership and the launch of the Ruffian EMP 270G welding generator signal growing interest in ESAB’s product portfolio and income-return profile. With ESAB maintaining its dividend and enhancing its welding offering, we’ll now examine how...

Simpson Manufacturing recently detailed in its 2025 10-K that it has opened new production facilities in Columbus, Ohio, and Gallatin, Tennessee, while launching over 50 new products across wood, mass timber, and concrete construction categories. This combination of expanded in-house manufacturing and a broad wave of product development highlights how Simpson is reshaping its cost base and deepening its role in structural building solutions. Next, we’ll examine how these new Ohio and...

Carpenter Technology (NYSE:CRS) has outlined a CEO succession plan with Brian Malloy scheduled to become Chief Executive Officer on July 1, 2026. Current CEO Tony Thene is expected to transition to the role of Executive Chairman as part of the planned leadership change. Malloy brings operational experience at Carpenter Technology and prior industry leadership that may influence future company priorities. Carpenter Technology enters this planned leadership transition with its shares at...

United Community Banks, Inc. previously announced that its Board approved a quarterly cash dividend of US$0.25 per share, payable on April 3, 2026 to shareholders of record as of March 13, 2026. The dividend decision underscores the bank’s ongoing commitment to returning cash to shareholders even as regional lenders face heightened scrutiny over credit risk and loan quality. Next, we’ll examine how this routine dividend declaration interacts with rising credit risk concerns to shape United...

In recent days, First Merchants Corporation completed its acquisition of First Savings Financial Group, continued investing in digital and community initiatives, declared both common and preferred dividends, and saw Director and First Vice President Larry W. Myers sell 5,000 shares, all against a backdrop of renewed concern about regional banks’ credit risk following hotter-than-expected inflation data. This combination of a completed merger that expands the bank’s southern Indiana...

In late February 2026, BioCryst Pharmaceuticals reported fourth-quarter 2025 revenue of US$406.56 million and net income of US$245.85 million, capping its first full year of profitability with US$874.84 million in revenue and US$263.86 million in net income. The move into sustained profitability, underpinned by strong ORLADEYO performance and the Astria Therapeutics acquisition that broadened its hereditary angioedema portfolio, marks a step-change in BioCryst’s financial and competitive...

In February 2026, Rackspace Technology reported fourth quarter 2025 revenue of US$682.8 million and a net loss of US$32.7 million, alongside full-year 2025 revenue of US$2.69 billion and a net loss of US$225.8 million, both narrower than the prior year. The company also issued 2026 revenue guidance of US$2.60 billion to US$2.70 billion, giving investors a clearer view of expected top-line stability while losses remain material. Next, we will examine how Rackspace’s narrower 2025 net loss and...

Houlihan Lokey filed an SEC prospectus supplement covering the resale of new Class A shares tied to recent acquisitions and performance milestones. The filing sets out how these newly issued shares can be resold by certain holders, clarifying the legal status of stock linked to completed deals. The move sheds light on how Houlihan Lokey structures equity based incentives for acquired teams and deal related performance. For you as an investor looking at NYSE:HLI, this filing provides an...

Belite Bio (BLTE) shares are under the spotlight after the company reported a fourth quarter net loss of US$25.32 million and a full year net loss of US$77.61 million, both above prior-year levels. See our latest analysis for Belite Bio. Despite the wider losses, Belite Bio’s share price has shown strong momentum, with a 26.16% 90 day share price return and a very large 1 year total shareholder return that sits near 5x. This may point to shifting expectations around its pipeline rather than...

Lineage (LINE) is back in focus after reporting fourth quarter and full year 2025 results, which included a swing to a Q4 profit and a sharply smaller annual net loss, catching investors’ attention. See our latest analysis for Lineage. At a share price of US$40.52, Lineage has seen a 5.8% 7 day share price return, a 13.5% 30 day share price return, and a 14.4% year to date share price return. However, its 1 year total shareholder return of a 29.3% decline shows that recent momentum is...

Why Qnity Electronics (Q) Is Back on Investors’ Radar Qnity Electronics (Q) has drawn fresh attention after reporting Q4 2025 results that topped analyst revenue and earnings expectations, rolling out a multi year productivity plan, and approving a US$500 million share repurchase program. See our latest analysis for Qnity Electronics. The strong Q4 surprise, fresh 2026 net sales guidance and new M&A ambitions have coincided with powerful momentum, with a 30 day share price return of 31.8% and...

Madison Square Garden Entertainment Corp. recently disclosed that a data breach discovered on or about December 16, 2025 exposed personal information via a vulnerability in Oracle’s eBusiness Suite, prompting legal investigations by Edelson Lechtzin LLP on behalf of affected individuals. Beyond potential legal and remediation costs, this incident puts the company’s data security and operational controls under scrutiny at a time when it relies heavily on customer trust for its live...

Chemed Corporation recently reported fourth-quarter 2025 results showing net income of US$76.75 million and full-year 2025 net income of US$265.24 million, both lower than the prior year, alongside 2026 adjusted earnings guidance of US$23.25–US$24.25 per diluted share. Despite ongoing share repurchases totaling US$2.62 billion since 2011, investors focused on pressure in VITAS and Roto-Rooter margins, including Medicare Cap constraints and water-restoration write-offs. We’ll now examine how...

Tarsus Pharmaceuticals (TARS) recently reported full year 2025 results, with revenue of US$451.36 million and a net loss of US$66.42 million, and also filed a US$141.73 million shelf registration. See our latest analysis for Tarsus Pharmaceuticals. The latest earnings improvement and governance changes appear to sit behind a strong share price recovery, with a 30 day share price return of 17.01% and a one year total shareholder return of 76.78%. This is despite the year to date share price...

In February 2026, Copart, Inc. reported that its second-quarter revenue slipped to US$1,121.67 million from US$1,163.32 million a year earlier, with net income easing to US$350.73 million and diluted earnings per share from continuing operations at US$0.36 versus US$0.40. An interesting contrast is that while quarterly revenue and profit dipped year over year, Copart’s net income for the first half of the fiscal year edged up slightly to US$754.45 million, with earnings per share essentially...

QuidelOrtho (QDEL) has drawn fresh investor attention after announcing a long-term supply agreement with Lifotronic Technology, giving the diagnostics company access to additional immunoassay analyzers and more than 70 assays across select markets outside the United States. See our latest analysis for QuidelOrtho. That supply agreement arrives at a time when QuidelOrtho’s share price has seen a 7.31% 7 day gain to US$22.74, but its year to date share price return of 20.99% and 1 year total...

Earnings and leadership changes draw focus to Erie Indemnity (ERIE) Erie Indemnity (ERIE) has moved into the spotlight after releasing its full year 2025 results, showing revenue of US$4,067.26 million alongside lower net income and earnings per share compared with the prior year. See our latest analysis for Erie Indemnity. Investors have been weighing the full year 2025 results and the planned CEO transition against recent market performance, with the share price at US$269.44 and a 1 year...

Without a specific news headline driving attention, Belden (BDC) is drawing interest as investors look at its recent share performance, business profile, and current financial footprint in data infrastructure and industrial connectivity. See our latest analysis for Belden. Belden’s share price has pulled back 2.7% over the last day but still sits at US$143.30 after a strong 30 day share price return of 21.95% and a 1 year total shareholder return of 30.46%, which points to momentum that has...

Metropolitan Bank Holding Corp. recently completed a follow-on public offering of 2,100,000 common shares at US$85.00 each, raising about US$178.5 million to bolster capital and fund organic growth, technology investment, and general corporate purposes. The move meaningfully expands the bank’s equity base while supporting its post–Project Phoenix push into technology and AI-driven efficiency, reshaping how it finances future expansion. We’ll now examine how this sizeable equity raise, aimed...

Asbury Automotive Group recently completed the sale of ten dealerships, generating about US$210 million in net proceeds and expanding its authorized share repurchase program to US$500 million, while also exiting a Chrysler Dodge Jeep Ram store that was acquired and rebranded as Indy CDJR by Matt Bowers. Together, these moves highlight Asbury’s ongoing portfolio reshaping and its preference to return capital to shareholders rather than reinvest all proceeds into owned dealership...